LABP Landos Biopharma, Inc.

Landos Biopharma, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of novel oral therapeutics for patients with autoimmune diseases. Our pipeline, which currently contains seven preclinical and clinical product candidates, leverages our LANCE precision medicine platform to optimally identify novel immunometabolic targets and address a wide range of disease indications.

$13.49  +0.50 (3.85%)
As of 02/26/2021 15:54:39 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA

02/04/2021
39,163,174
637,931
$527,919,586
0.00%
SEC Edgar Online
10-Q
10-K



Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
-11.93
0.00
7.93%
0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy